Latest Period
Q4 2025
Security Snapshot
Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG) Institutional Ownership
CUSIP: 005329107
13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025
Institutions Reporting
17
Shares (Excl. Options)
3,089,667
Price
$1.89
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Ordinary shares, par value US$0.0001 per share
- Symbol
- ADAG on Nasdaq
- Shares outstanding
- 46,844,314
- Price per share
- $2.84
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 3,089,667
- Total reported value
- $6,027,495
- % of total 13F portfolios
- 0%
- Share change
- -2,672,764
- Value change
- -$5,437,806
- Number of holders
- 17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ADAG - Adagene Inc. - Ordinary shares, par value US$0.0001 per share is tracked under CUSIP 005329107.
- 17 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 17 to 17 between Q3 2025 and Q4 2025.
- Reported value moved from $11,251,842 to $6,027,495.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 17 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 005329107?
CUSIP 005329107 identifies ADAG - Adagene Inc. - Ordinary shares, par value US$0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue With The Right Next Step
- Latest 13F filings - identify new institutional portfolio moves.
- Latest Schedule 13D/13G reports - cross-check beneficial ownership events.
- All institutional ownership pages - compare nearby CUSIPs and holder concentration.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 005329107:
Significant Owners of Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Luo Peter | 16% | $12,937,369 | 9,175,439 | HAN 2020 Irrevocable Trust | 25 Jan 2025 | |||
| Smith Vincent C | 8.7% | +26% | $9,120,679 | +$2,258,166 | 5,095,351 | +33% | Smith Vincent C | 31 Dec 2025 |
| WuXi PharmaTech Healthcare Fund I L.P. | 7% | -17% | $8,187,161 | -$1,701,888 | 4,121,815 | -17% | WuXi PharmaTech Healthcare Fund I L.P. | 30 Sep 2025 |
| Chernett Jorey | 5.1% | $7,764,445 | 2,389,060 | Chernett Jorey | 16 Mar 2026 | |||
| Panacea Innovation Ltd | 3.8% | -28% | $4,469,175 | -$1,564,211 | 2,250,000 | -26% | Panacea Venture Healthcare Fund II, L.P. | 30 Sep 2025 |
| FIL Ltd | 1.8% | -75% | $1,320,902 | -$4,450,930 | 936,810 | -77% | FIL Limited | 31 Mar 2025 |
| FMR LLC | 0.9% | $933,679 | 473,949 | FMR LLC | 30 Jun 2025 |
As of 31 Dec 2025, 17 institutional investors reported holding 3,089,667 shares of Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG). This represents 6.6% of the company’s total 46,844,314 outstanding shares.
Institutional Holders of Adagene Inc. - Ordinary shares, par value US$0.0001 per share (ADAG) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 3,089,667 | $6,027,495 | -$5,437,806 | $1.89 | 17 |
| 2025 Q3 | 5,722,260 | $11,251,842 | -$681,939 | $1.99 | 17 |
| 2025 Q2 | 6,066,432 | $11,842,205 | -$2,692,639 | $1.95 | 15 |
| 2025 Q1 | 7,596,934 | $11,574,144 | -$4,448,523 | $1.54 | 13 |
| 2024 Q4 | 10,441,972 | $20,299,608 | +$6,443,398 | $1.99 | 15 |
| 2024 Q3 | 11,157,880 | $25,316,756 | -$140,637 | $2.22 | 13 |
| 2024 Q2 | 11,223,549 | $33,703,166 | -$3,006,648 | $3.06 | 14 |
| 2024 Q1 | 12,297,346 | $34,335,526 | +$14,585,257 | $2.80 | 17 |
| 2023 Q4 | 5,781,239 | $11,163,839 | -$2,205,992 | $1.93 | 10 |
| 2023 Q3 | 4,096,719 | $6,164,993 | -$21,756 | $1.53 | 10 |
| 2023 Q2 | 4,111,294 | $6,016,229 | -$108,766 | $1.48 | 10 |
| 2023 Q1 | 4,186,071 | $6,023,400 | -$44,708 | $1.45 | 11 |
| 2022 Q4 | 4,216,842 | $5,581,186 | -$2,280,668 | $1.32 | 9 |
| 2022 Q3 | 5,940,279 | $7,603,000 | -$2,338,985 | $1.28 | 11 |
| 2022 Q2 | 7,531,358 | $15,421,000 | -$3,922,354 | $2.03 | 15 |
| 2022 Q1 | 8,391,600 | $29,674,000 | -$1,196,241 | $3.56 | 15 |
| 2021 Q4 | 8,373,818 | $67,324,000 | -$5,705,274 | $8.01 | 16 |
| 2021 Q3 | 8,786,888 | $126,610,000 | +$41,051,156 | $14.37 | 19 |
| 2021 Q2 | 5,937,931 | $80,519,000 | -$12,766,604 | $13.56 | 16 |
| 2021 Q1 | 6,435,237 | $115,522,000 | +$115,522,000 | $17.95 | 27 |